Palvella Therapeutics Inc. – Filings and Transcripts

NASDAQ: PVLA
Share price (11/10/26): $168.71
Market cap (11/10/26): $2.466 billion

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 09/30/26 Q3

ended 06/30/26 Q2

ended 03/31/26 Q1

ended 12/31/25 FY 2025

ended 09/30/25 Q3

Prospectuses and Registrations Filter

Registration of securities for employees

Prospectus supplement for primary offering

Prospectus supplement for primary offering

Shelf registration

Registration of securities for employees

Ownership Filter

Martini Jeffrey S

Jennison Associates LLC

Jenkins George M

News Filter

Reports Third Quarter 2026 Financial Results and Provides Corporate Update

Announces FDA Acceptance and Priority Review of QTORIN™ Rapamycin NDA; February 28, 2027 PDUFA Target Action Date Set

Reports Second Quarter 2026 Financial Results and Provides Corporate Update

Investor Presentation

Change in Directors, Officers or Compensation

Proxies Filter

Additional info about upcoming vote

Definitive proxy

Additional info about upcoming vote

Definitive proxy

Definitive proxy

Other Filter

Scanned paper annual report submission

Notice of effectiveness

Correspondence with the SEC

Letter from the SEC

Scanned paper annual report submission